Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» advanced breast cancer
advanced breast cancer
FDA hastily approves Daiichi Sankyo/AZ’s cancer drug, weeks after US filing
Pharmaforum
Mon, 12/23/19 - 11:46 pm
FDA
AstraZeneca
Daiichi Sankyo
advanced breast cancer
Enhertu
Here's Why Seattle Genetics Stock Jumped 25.7% in October
Motley Fool
Thu, 11/7/19 - 10:56 pm
Seattle Genetics
breast cancer
advanced breast cancer
clinical trials
tucatinib
Novartis gets FDA nod for advanced breast-cancer treatment
Marketwatch
Sun, 05/26/19 - 11:19 am
Novartis
FDA
advanced breast cancer
Piqray
Large and Small: Here’s What’s Moving Eli Lilly and Zosano
Yahoo/Market Exclusive
Tue, 02/27/18 - 09:48 am
Eli Lilly
Zosano
Verzenio
advanced breast cancer
M207
migraine
In a showdown with AstraZeneca, Pfizer posts solid — and very familiar — PhIII breast cancer data for talazoparib
Endpoints
Fri, 12/8/17 - 11:46 am
Pfizer
AstraZeneca
talazoparib
advanced breast cancer
Lynparza
PARP inhibitors
AstraZeneca's Faslodex Gets FDA Nod in First-Line Setting
Yahoo/Zacks.com
Mon, 08/28/17 - 09:35 am
AstraZeneca
Faslodex
FDA
advanced breast cancer
3 Most Promising Cancer Drugs in Late-Stage Development
Motley Fool
Tue, 08/22/17 - 10:04 am
Eli Lilly
abemaciclib
advanced breast cancer
Incyte
epacadostat
Imbruvica
JNJ
prostate cancer
Novartis, IBM Watson collab to optimize care for patients with advanced breast cancer
Drug Delivery Business News
Mon, 06/5/17 - 12:07 pm
Novartis
IBM Watson
advanced breast cancer
patients
breast cancer
Eli Lilly says breast cancer combination treatment improved survival rates in late-stage trial
Marketwatch
Mon, 04/24/17 - 10:07 am
Eli Lilly
advanced breast cancer
clinical trials
abemaciclib
Pfizer an Count on Ibrance for Upside and Massive Sales
Bidness, ETC
Mon, 02/22/16 - 09:33 am
Pfizer
Ibrance
breast cancer
advanced breast cancer
Lilly Receives FDA Breakthrough Therapy Designation for Abemaciclib - a CDK 4 and 6 Inhibitor - in Advanced Breast Cancer
Yahoo
Thu, 10/8/15 - 09:13 am
Eli Lilly
abemaciclib
advanced breast cancer
FDA
breakthrough therapies
Pfizer Announces $3 Million Grants Program to Further Clinical Research in Advanced Breast Cancer
Yahoo
Thu, 05/28/15 - 09:48 am
Pfizer
breast cancer
grants
R&D
advanced breast cancer
Pfizer Announces FDA Acceptance Of Palbociclib New Drug Application With Priority Review
Yahoo
Mon, 10/13/14 - 08:35 am
Pfizer
palbociclib
FDA
advanced breast cancer